Skip to content

Tongren-ophthalmology Research Association of Clinical Evaluation

Tongren-ophthalmology Research Association of Clinical Evaluation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-EPC-17013892
Enrollment
Unknown
Registered
2017-12-13
Start date
2015-10-20
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fundus diseases

Interventions

treated group A:plaque radiotherapy
treated group B:transpupillary thermotherapy

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All kinds of ocular tumors (including benign and malignant tumors); 2. High myopia; 3. All kinds of macular degeneration diseases (such as age-related macular degeneration and congenital macular dystrophy / degenerative diseases such as stargdt's disease); 4. Primary retinal detachment; 5. Diabetic retinopathy; 6. Other rare eye diseases.

Exclusion criteria

Exclusion criteria: Patients reject participation

Design outcomes

Primary

MeasureTime frame
survival;

Secondary

MeasureTime frame
metastasis;

Countries

China

Contacts

Public ContactWenbin Wei

Beijing Tongren Hospital, Capital Medical University

tr_weiwenbin@163.com+86 13701255115

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026